Bridge Program for Eligible Patients with Insurance Delay

ONC has established a Bridge program to assist eligible patients obtain their initial prescription of TEPMETKO® (tepotinib) free of charge, if the following criteria are met. The patient must:

  1. Be a new patient with a prescription for TEPMETKO
  2. Be diagnosed by their physician with the FDA approved indication of TEPMETKO.
  3. Be insured (i.e., a commercial insurer or a federal health care program)
  4. Have experienced a delay in a coverage determination of at least 5 business days

Please fax a completed ONC Enrollment Form to verify benefits or request assistance.

This site is intended only for US residents 18 years of age or older